<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Bramble: GSK</title>
    <link>https://news.ketelle.co.uk/entities/gsk</link>
    <description>Stories involving GSK, told neutrally, with how each side covers them.</description>
    <language>en-gb</language>
    <atom:link href="https://news.ketelle.co.uk/entities/gsk/feed.xml" rel="self" type="application/rss+xml"/>
    <item>
      <title>GSK shares fall as vaccine sales drop 2% in third quarter despite higher profits</title>
      <link>https://news.ketelle.co.uk/stories/gsk-shares-fall-as-vaccine-sales-drop-in-third-quarter</link>
      <guid isPermaLink="true">https://news.ketelle.co.uk/stories/gsk-shares-fall-as-vaccine-sales-drop-in-third-quarter</guid>
      <pubDate>Wed, 28 Oct 2026 12:41:29 +0000</pubDate>
      <category>Business</category>
      <description>GSK shares fell on 28 October after it reported a 2% drop in third-quarter vaccine sales to £2.6bn, even though group sales and core operating profit rose. The two outlets differ on the size of the share fall and of the drop in Arexvy sales. (2 outlets: 0 left · 1 centre · 1 right)</description>
      <media:content url="https://www.cityam.com/wp-content/uploads/2026/10/scientist-inspecting-paperwork-in-lab-e1793180863970.jpg" medium="image"/>
    </item>
  </channel>
</rss>
